More reads

• Sen. Bill Cassidy: How will we pay for the coming generation of potentially curative gene therapies? (STAT)
• Biotech investors need bigger targets. (Wall Street Journal)
• Intermountain, Amgen subsidiary to launch DNA study of 500,000 patients (STAT)
• China’s pharma shake-up wins healthy endorsement. (Reuters)